The recent BIO International Convention not only brought showcasing opportunities for the state and its unparalleled life sciences assets, but also several exciting announcements from Maryland-based companies.
Horizon Therapeutics, a global biotech business focused on addressing autoimmune and inflammatory diseases, is working on quadrupling its space in Montgomery County. The company currently has a new state-of-the-art lab under construction with completion planned for 2024. Horizon anticipates doubling its employees in Maryland, with room in the new facility for more than 200 scientists.